AUTONOMOUS DISORDERS IN CMT (CMT-autonom)
Hereditary neuropathies are a phenotypically and genetically heterogeneous group of disorders. One of the most common forms is Charcot-Marie-Tooth neuropathy (CMT), which can be further divided into demyelinating (CMT1) and axonal (CMT2) neuropathies, as well as various pathogenic genetic variants. In addition to the clinically predominant motor and sensory deficits, symptoms of the autonomic nervous system have also been described in patients with CMT, often leading to significant limitations in daily functioning and quality of life. However, little is known about the prevalence and extent of autonomic dysfunction in CMT patients.
In this study, patients with CMT will be assessed for the presence, severity, and characteristics of autonomic dysfunction using questionnaires and non-invasive diagnostic methods. Furthermore, diagnosis, genotype, and individual disease data-such as disease duration, severity of neurological impairment, and comorbidities-will be collected from patient records.
The aim of this study is to evaluate and characterize autonomic dysfunction in patients with CMT. It seeks to determine how frequently autonomic dysfunction occurs in CMT, which areas of the autonomic nervous system are most commonly affected, whether risk factors exist, and what differences can be observed between the various CMT subtypes. The findings of this study are expected to provide new insights into the role of autonomic dysfunction in CMT, ultimately contributing to improved care and treatment for affected patients.
研究概览
地位
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Michael W Sereda, Prof. MD
- 电话号码:+49 551 3964162
- 邮箱:sereda@mpinat.mpg.de
学习地点
-
-
Lower Saxony
-
Göttingen、Lower Saxony、德国、37075
- 招聘中
- University Medical Centre
-
接触:
- Sandrin Plewe
- 电话号码:+49 551 3964162
- 邮箱:sandrin.plewe@med.uni-goettingen.de
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Clinical CMT Diagnosis / Anamnestically Healthy Control Group
- Genetic confirmation of CMT in adult patients
- Ability to achieve the outcome measure at baseline
- Age between 18 and 65 years
- Capacity of all study participants to consent and signed informed consent, - including patient or participant information and consent form
Exclusion Criteria:
- Pregnancy or breastfeeding period
- Other relevant neurological or psychiatric disorders, acute or in the past history
- Presence of a serious previous internal disease
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
CMT患者
|
|
控件
健康年龄匹配的对照
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
COMPASS 31
大体时间:baseline
|
validated questionaire
|
baseline
|
|
electrophysiological measurement
大体时间:baseline
|
Validated electrophysiological examinations including the sympathetic skin reflex, the Schellong test, and heart rate variability measurement
|
baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
muscle strength
大体时间:baseline
|
baseline
|
|
|
neurography
大体时间:baseline
|
Examinations measuring the electrical activity and conductivity of nerves, which are used to diagnose nerve damage or diseases.
|
baseline
|
|
nerve sonography
大体时间:at visit
|
at visit
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 17/05/2024_C2
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.